UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 454

Sortiert nach

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Journal of the neurological sciences, 2020-05, Vol.412, p.116803-116803, Article 116803

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic advances in neuromuscular diseases in 2023

Lancet neurology, 2024-01, Vol.23 (1), p.24-25

Vissing, John

2024

Link zum Volltext

Verfügbarkeit prüfen

229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

Neuromuscular disorders : NMD, 2018-08, Vol.28 (8), p.702-710

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome

JAMA neurology, 2014-03, Vol.71 (3), p.350

2014

Link zum Volltext

Verfügbarkeit prüfen

Aerobic Training in Patients with Congenital Myopathy

PloS one, 2016, Vol.11 (1), p.e0146036-e0146036

2016

Link zum Volltext

Verfügbarkeit prüfen

Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies

Current opinion in neurology, 2016-10, Vol.29 (5), p.635-641

Vissing, John

2016

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies

Neurology, 2020-03, Vol.94 (10), p.e1094

2020

Link zum Volltext

Verfügbarkeit prüfen

Paternal comeback in mitochondrial DNA inheritance

Proceedings of the National Academy of Sciences - PNAS, 2019-01, Vol.116 (5), p.1475-1476

Vissing, John

2019

Link zum Volltext

Verfügbarkeit prüfen

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis

Expert opinion on investigational drugs, 2021-05, Vol.30 (5), p.483-493

2021

Link zum Volltext

Verfügbarkeit prüfen

Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders

Scientific reports, 2023-02, Vol.13 (1), p.2538-2538, Article 2538

2023

Link zum Volltext

Verfügbarkeit prüfen

Physical activity in myotonic dystrophy type 1

Journal of neurology, 2020-06, Vol.267 (6), p.1679-1686

2020

Link zum Volltext

Verfügbarkeit prüfen

Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation

Orphanet journal of rare diseases, 2023-07, Vol.18 (1), p.210-210, Article 210

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study

PloS one, 2013-08, Vol.8 (8), p.e70993-e70993

2013

Link zum Volltext

Verfügbarkeit prüfen

High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1

Genes, 2022-05, Vol.13 (6), p.970

2022

Link zum Volltext

Verfügbarkeit prüfen

Decreased variability of the 6-minute walk test by heart rate correction in patients with neuromuscular disease

PloS one, 2014-12, Vol.9 (12), p.e114273-e114273

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutation Load of Single, Large-Scale Deletions of mtDNA in Mitotic and Postmitotic Tissues

Frontiers in genetics, 2020-10, Vol.11, p.547638-547638

2020

Link zum Volltext

Verfügbarkeit prüfen

Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency

Molecular genetics and metabolism, 2017-11, Vol.122 (3), p.117-121

2017

Link zum Volltext

Verfügbarkeit prüfen

Muscle atrophy reversed by growth factor activation of satellite cells in a mouse muscle atrophy model

PloS one, 2014-06, Vol.9 (6), p.e100594

2014

Link zum Volltext

Verfügbarkeit prüfen

High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark

Annals of neurology, 2006-05, Vol.59 (5), p.808-815

2006

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy-A 1-Year Follow-Up Study

Frontiers in neurology, 2021-01, Vol.11, p.613489-613489

2021

Link zum Volltext

Verfügbarkeit prüfen

Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency

Neurology, 2018-09, Vol.91 (11), p.e1077

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study

PloS one, 2014-02, Vol.9 (2), p.e90377-e90377

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis

PloS one, 2016-10, Vol.11 (10), p.e0164092-e0164092

2016

Link zum Volltext

Verfügbarkeit prüfen

Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.533

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E

Neurology, 2015-04, Vol.84 (17), p.1772

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(397)

Publikationsform

Sprache

Englisch
(448)
Japanisch
(36)
Dänisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Therapeutic advances in neuromuscular diseases in 2023

229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome

Aerobic Training in Patients with Congenital Myopathy

Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies

Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies

Paternal comeback in mitochondrial DNA inheritance

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis

Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders

Physical activity in myotonic dystrophy type 1

Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation

Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study

High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1

Decreased variability of the 6-minute walk test by heart rate correction in patients with neuromuscular disease

Mutation Load of Single, Large-Scale Deletions of mtDNA in Mitotic and Postmitotic Tissues

Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency

Muscle atrophy reversed by growth factor activation of satellite cells in a mouse muscle atrophy model

High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark

Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy-A 1-Year Follow-Up Study

Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency

Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study

Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis

Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success

Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E

Suchergebnisse filtern